A carregar...

Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis

BACKGROUND: Targeting CTLA-4 is a recent strategic approach in cancer control: blocking CTLA-4 enhances an antitumor immunity by promoting T-cell activation and cytotoxic T-lymphocyte proliferation. This induction of a tolerance break against the tumor may be responsible for immune-related adverse e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Med
Main Authors: Bertrand, Anne, Kostine, Marie, Barnetche, Thomas, Truchetet, Marie-Elise, Schaeverbeke, Thierry
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559965/
https://ncbi.nlm.nih.gov/pubmed/26337719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0455-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!